Obesity

FDA Updates Warning on Intragastric Balloons After 5 Deaths

FDA Approves: New Hepatitis C Drug

The FDA last week issued an updated warning letter on intragastric balloons to alert health care providers to 5 deaths that occurred over the last year in patients treated for obesity with the liquid-filled balloon systems.  The original warning, that the FDA issued 6 months ago,  addressed two possible adverse events, over inflation with either liquid of…

Read More